Corticosteroids adrenal gland

There is no evidence of safe and effective use of topical corticosteroids in pregnant mothers. Therefore, they should be used only if clearly needed. Long term use and large applications of topical corticosteroids may cause birth defects in the unborn. It is not known whether topical corticosteroids enter breast milk. Therefore, caution must be exercised before using it in nursing mothers. Topical corticosteroids should not be applied to the breasts of nursing mothers unless the mothers instructed to do so by the physician.

Long-acting corticosteroids improve lung function by suppressing inflammation in the respiratory passages and help reduce the need for oral medication. Types of long-acting corticosteroids and their usual daily dosages pinclude the following:

  • Aerospan (flunisolide HFA)—2 inhalations 2x/day
  • Alvesco (ciclesonide)—1-2 inhalations 2x/day
  • Asmanex Twisthaler (mometasone)—1 inhalation 2x/day or 2 inhalations 1x/day
  • Flovent HFA (fluticasone)—1-4 inhalations 2x/day
  • Pulmicort Flexhaler (budesonide)—1-2 inhalations 2x/day
  • QVAR (beclomethasone)—1-4 inhalations 2x/day

An example of an acute hepatitis-like syndrome arising after pulse methylprednisolone therapy.  These episodes arise typically 2 to 4 weeks after a third or fourth cycle of pulse therapy, and range in severity from an asymptomatic and transient rise in serum aminotransferase levels to an acute hepatitis and even fulminant hepatic failure.  In this instance, the marked and persistent rise in serum enzymes coupled with liver histology suggesting chronic hepatitis led to a diagnosis of new-onset autoimmune hepatitis, despite the absence of serum autoantibodies or hypergammaglobulinemia.  Autoimmune hepatitis may initially present in this fashion, without the typical pattern of serum autoantibodies during the early, anicteric phase.  The diagnosis was further supported by the prompt improvements in serum enzymes with prednisone therapy.  The acute hepatitis-like syndrome that can occur after pulses of methylprednisolone is best explained as a triggering of an underlying chronic autoimmune hepatitis caused by the sudden and profound immunosuppression followed by rapid withdrawal.  This syndrome can be severe, and fatal instances have been reported.  Whether reinitiation of corticosteroid therapy with gradual tapering and withdrawal is effective in ameliorating the course of illness is unclear, but anecdotal reports such as this one suggest that they are beneficial and should be initiated promptly on appearance of this syndrome.  Long term follow up of such cases is also necessary to document that the autoimmune hepatitis does not relapse once corticosteroids are withdrawn again.

Corticosteroids adrenal gland

corticosteroids adrenal gland

Media:

corticosteroids adrenal glandcorticosteroids adrenal glandcorticosteroids adrenal glandcorticosteroids adrenal glandcorticosteroids adrenal gland